Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

PrEP news

Show

From To
Bacterial vaginosis does not affect efficacy of oral PrEP in women

Research presented at the Conference on Retroviruses and Opportunistic Infections (CROI 2017) found that the efficacy of oral PrEP for women was not affected by bacterial

Published
23 February 2017
By
Gus Cairns
STI rates in PrEP users very high, but evidence that PrEP increases them is inconclusive

A study of PrEP users presented at the Conference on Retroviruses and Opportunistic Infections (CROI 2017) last week, from CROI’s host city of Seattle, showed

Published
22 February 2017
By
Gus Cairns
Mr Gay NZ defends his view that having unprotected sex with HIV can be safe

The new Mr Gay New Zealand, who is HIV positive, is defending having unprotected sex, saying he always informs sexual partners of his health status. He said he only had unprotected sex with HIV positive men or HIV negative men who he knew were on Pre-exposure prophylaxis (PrEP), which was a pill that reduced the risk of them getting HIV.

Published
21 February 2017
From
New Zealand Herald
PrEP uses contributes to decline in STI incidence among MSM

Results from a modeling study presented at the Conference on Retroviruses and Opportunistic Infections (CROI) 2017 indicated that the use of pre-exposure prophylaxis for HIV prevention in addition to routine screening and treatment of sexually transmitted infections, or STIs, could reduce the incidence of STIs among men who have sex with men, even when condom use was reduced.

Published
20 February 2017
From
Healio
When science, community and political will come together, we can end the epidemic, says New York commissioner

New York City’s strategy to end the HIV epidemic is firmly rooted in science, was developed in conjunction with community activists, and has support from top-level political

Published
17 February 2017
By
Roger Pebody
Unique case of PrEP failure without drug resistance reported from Amsterdam

HIV pre-exposure prophylaxis (PrEP) appears to be nearly 100% effective if taken consistently so that there are high drug levels in the body at the time of

Published
17 February 2017
By
Gus Cairns
Oral PrEP Works Well in Women With Abnormal Vaginal Microbiota

This challenges a finding that an anti-HIV vaginal gel might not be effective in women with abnormal vaginal flora.

Published
16 February 2017
From
Poz
Vaginal Ring Form of PrEP Does Not Reduce Contraceptive Effectiveness

The antiretroviral (ARV)-containing vaginal ring form of pre-exposure prophylaxis (PrEP) that reduced HIV risk in a major trial does not lower the effectiveness of hormonal birth control. This finding assuages concerns raised by previous research that the non-nucleoside reverse transcriptase inhibitor (NNRTI) class of ARVs has been associated with a lowered effectiveness of some hormonal contraceptives.

Published
16 February 2017
From
Poz
One-stop sexual health: PrEP services at your local pharmacy

Pharmacists—who work across centers that range from community clinics, to pharmacies in grocery stores, to stand-alone retail centers—may be an untapped resource as potential PrEP service providers. This was the subject up for discussion at a recent session at CROI, where two presenters shed light on the feasibility of pharmacist-delivered PrEP services.

Published
16 February 2017
From
BETA blog
Experimental STI prophylaxis in PrEP users produces big drops in syphilis and chlamydia infections but not in gonorrhoea

Use of the antibiotic doxycycline as on-demand post-exposure prophylaxis by men who have sex with men (MSM) taking part in the Ipergay HIV pre-exposure prophylaxis (PrEP)

Published
15 February 2017
By
Gus Cairns
← First12345...107Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.